Sarepta Therapeutics (SRPT) EBITDA Margin (QoQ) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,247.00 |
| Dec 31, 2025 | -4,793.00 |
| Sep 30, 2025 | -7,720.00 |
| Jun 30, 2025 | 25,750.00 |
| Mar 31, 2025 | -24,985.00 |
| Dec 31, 2024 | 1,666.00 |
| Sep 30, 2024 | 621.00 |
| Jun 30, 2024 | -666.00 |
| Mar 31, 2024 | -184.00 |
| Dec 31, 2023 | 2,240.00 |
| Sep 30, 2023 | 9,824.00 |
| Jun 30, 2023 | 9,290.00 |
| Mar 31, 2023 | -13,970.00 |
| Dec 31, 2022 | 6,073.00 |
| Sep 30, 2022 | -1,376.00 |
| Jun 30, 2022 | 36,794.00 |
| Mar 31, 2022 | -36,964.00 |
| Dec 31, 2021 | -8,351.00 |
| Sep 30, 2021 | 3,196.00 |
| Jun 30, 2021 | 5,644.00 |
| Mar 31, 2021 | 72,776.00 |
| Dec 31, 2020 | 3,198.00 |
| Sep 30, 2020 | -29,155.00 |
| Jun 30, 2020 | -45,411.00 |
| Mar 31, 2020 | 10,755.00 |
| Dec 31, 2019 | -10,791.00 |
| Sep 30, 2019 | 16,435.00 |
| Jun 30, 2019 | -20,396.00 |
| Mar 31, 2019 | 7,909.00 |
| Dec 31, 2018 | -7,017.00 |
| Sep 30, 2018 | 5,136.00 |
| Jun 30, 2018 | -9,307.00 |
| Mar 31, 2018 | -1,261.00 |
| Dec 31, 2017 | 6,128.00 |
| Sep 30, 2017 | 7,621.00 |
| Jun 30, 2017 | -69,499.00 |
| Dec 31, 2014 | -16.19 Mn |
| Sep 30, 2014 | -145,126.00 |
| Jun 30, 2014 | -84,512.00 |
| Mar 31, 2014 | -12,950.00 |
| Dec 31, 2013 | 67,253.00 |
| Sep 30, 2013 | -36,282.00 |
| Jun 30, 2013 | 29,506.00 |
| Mar 31, 2013 | -9,457.00 |
| Dec 31, 2012 | -19,180.00 |
| Sep 30, 2012 | -72,599.00 |
| Jun 30, 2012 | 22,963.00 |